CH692199A8 - Composes pyridiques et compositions pharmaceutique - Google Patents
Composes pyridiques et compositions pharmaceutique Download PDFInfo
- Publication number
- CH692199A8 CH692199A8 CH02364/97A CH236497A CH692199A8 CH 692199 A8 CH692199 A8 CH 692199A8 CH 02364/97 A CH02364/97 A CH 02364/97A CH 236497 A CH236497 A CH 236497A CH 692199 A8 CH692199 A8 CH 692199A8
- Authority
- CH
- Switzerland
- Prior art keywords
- compounds
- pharmaceutical compositions
- pyridic
- oxydation
- dihydropyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH02364/97A CH692199A8 (fr) | 1997-10-09 | 1997-10-09 | Composes pyridiques et compositions pharmaceutique |
ES98945453T ES2206989T3 (es) | 1997-10-09 | 1998-10-07 | Compuestos de piridilo y composiciones farmaceuticas que los contienen. |
DE69818286T DE69818286T2 (de) | 1997-10-09 | 1998-10-07 | Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen |
AU92771/98A AU747150B2 (en) | 1997-10-09 | 1998-10-07 | Pyridyl compounds and pharmaceutical compositions containing them |
PT98945453T PT1023267E (pt) | 1997-10-09 | 1998-10-07 | Compostos de piridilo e composicoes farmaceuticas que os contem |
EP98945453A EP1023267B1 (fr) | 1997-10-09 | 1998-10-07 | Composes de pyridyle et compositions pharmaceutiques contenant ces composes |
CA002306789A CA2306789A1 (fr) | 1997-10-09 | 1998-10-07 | Composes de pyridyle et compositions pharmaceutiques contenant ces composes |
AT98945453T ATE250034T1 (de) | 1997-10-09 | 1998-10-07 | Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen |
US09/529,112 US6482841B1 (en) | 1997-10-09 | 1998-10-07 | Pyridyl compounds and pharmaceutical compositions containing them |
JP2000515875A JP2001519415A (ja) | 1997-10-09 | 1998-10-07 | ピリジル化合物およびこれを含有した薬剤組成物 |
PCT/IB1998/001555 WO1999019302A1 (fr) | 1997-10-09 | 1998-10-07 | Composes de pyridyle et compositions pharmaceutiques contenant ces composes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH02364/97A CH692199A8 (fr) | 1997-10-09 | 1997-10-09 | Composes pyridiques et compositions pharmaceutique |
Publications (2)
Publication Number | Publication Date |
---|---|
CH692199A5 CH692199A5 (fr) | 2002-03-15 |
CH692199A8 true CH692199A8 (fr) | 2002-06-14 |
Family
ID=4232069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH02364/97A CH692199A8 (fr) | 1997-10-09 | 1997-10-09 | Composes pyridiques et compositions pharmaceutique |
Country Status (11)
Country | Link |
---|---|
US (1) | US6482841B1 (fr) |
EP (1) | EP1023267B1 (fr) |
JP (1) | JP2001519415A (fr) |
AT (1) | ATE250034T1 (fr) |
AU (1) | AU747150B2 (fr) |
CA (1) | CA2306789A1 (fr) |
CH (1) | CH692199A8 (fr) |
DE (1) | DE69818286T2 (fr) |
ES (1) | ES2206989T3 (fr) |
PT (1) | PT1023267E (fr) |
WO (1) | WO1999019302A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE267810T1 (de) * | 2000-06-08 | 2004-06-15 | Bayer Chemicals Ag | Verfahren zur herstellung von pyridinen durch oxidation von dihydropyridinen mittels methylnitrit |
DE10115945A1 (de) * | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
AU2002368531A1 (en) * | 2002-12-30 | 2004-07-22 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. | Isolation of dihydropyridine derivative and preparation salts thereof |
US10130624B2 (en) * | 2005-03-15 | 2018-11-20 | Lupin Limited | Pharmaceutical compositions of amlodipine and benazepril |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
JP2009513604A (ja) | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体 |
CA2642368A1 (fr) * | 2006-02-28 | 2007-09-07 | Boehringer Ingelheim International Gmbh | Traitement ou prevention de la cardiopathie valvulaire par la flibanserine |
RS54398B1 (en) * | 2006-05-09 | 2016-04-28 | Sprout Pharmaceuticals, Inc. | THE USE OF FLIBANSERINE FOR THE TREATMENT OF SEXUAL DESIRE DISORDERS IN POSTMENOPAUSE |
JP2009541443A (ja) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 尿失禁及び関連疾患の治療のためのフリバンセリン |
WO2008006838A1 (fr) * | 2006-07-14 | 2008-01-17 | Boehringer Ingelheim International Gmbh | Utilisation de flibansérine pour le traitement de troubles sexuels chez les femmes |
KR20090042967A (ko) | 2006-08-14 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 플리반세린 제형 및 이의 제조방법 |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
EA200900270A1 (ru) * | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
WO2008090742A1 (fr) * | 2007-01-23 | 2008-07-31 | National University Corporation Hokkaido University | Animal non humain pour un modèle de maladie des yeux |
UY31335A1 (es) | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
US10576072B2 (en) * | 2016-01-26 | 2020-03-03 | Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi | N3,N6-bis(2-(5-methoxy-1H-indole-3-yl)ethyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxamide and use thereof in the field of neurotoxicity |
CN109020875B (zh) * | 2018-08-27 | 2020-05-22 | 北京市药品检验所 | 二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途 |
JP7333105B2 (ja) * | 2019-05-31 | 2023-08-24 | アールディスカバリー エルエルシー | Drp1-フィラミン複合体形成阻害剤 |
CN112457242B (zh) * | 2020-12-03 | 2021-11-23 | 广州隽沐生物科技股份有限公司 | 一种拉西地平杂质b的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3209276A1 (de) * | 1982-03-13 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung |
EP0179239A3 (fr) * | 1984-09-17 | 1986-08-13 | Sterling Drug Inc. | Acide 7-(pyridinyl)-/-alkyl-1,4-dihydro-4-oxo-3-quinoléine carboxylique ayant une activité antibactérienne et sa préparation |
US4698350A (en) * | 1984-09-17 | 1987-10-06 | Sterling Drug Inc. | 1-ethyl-6-fluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and antibacterial use thereof |
CA1312611C (fr) | 1987-07-01 | 1993-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | Derives pyridine, procede pour leur production et composition pharmaceutique en contenant |
GB8905526D0 (en) | 1989-03-10 | 1989-04-19 | Fujisawa Pharmaceutical Co | N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same |
DE4200714A1 (de) | 1992-01-14 | 1993-07-15 | Bayer Ag | Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung |
JP3286645B2 (ja) | 1993-03-26 | 2002-05-27 | メルシャン株式会社 | 光学活性1,4−ジヒドロピリジン誘導体およびその製造方法 |
DE4430639A1 (de) | 1994-08-29 | 1996-03-07 | Bayer Ag | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten |
US6066642A (en) * | 1996-01-29 | 2000-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists |
-
1997
- 1997-10-09 CH CH02364/97A patent/CH692199A8/fr not_active IP Right Cessation
-
1998
- 1998-10-07 PT PT98945453T patent/PT1023267E/pt unknown
- 1998-10-07 EP EP98945453A patent/EP1023267B1/fr not_active Expired - Lifetime
- 1998-10-07 JP JP2000515875A patent/JP2001519415A/ja active Pending
- 1998-10-07 AU AU92771/98A patent/AU747150B2/en not_active Ceased
- 1998-10-07 ES ES98945453T patent/ES2206989T3/es not_active Expired - Lifetime
- 1998-10-07 AT AT98945453T patent/ATE250034T1/de not_active IP Right Cessation
- 1998-10-07 CA CA002306789A patent/CA2306789A1/fr not_active Abandoned
- 1998-10-07 US US09/529,112 patent/US6482841B1/en not_active Expired - Fee Related
- 1998-10-07 DE DE69818286T patent/DE69818286T2/de not_active Expired - Fee Related
- 1998-10-07 WO PCT/IB1998/001555 patent/WO1999019302A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2206989T3 (es) | 2004-05-16 |
PT1023267E (pt) | 2004-01-30 |
EP1023267B1 (fr) | 2003-09-17 |
US6482841B1 (en) | 2002-11-19 |
AU747150B2 (en) | 2002-05-09 |
CH692199A5 (fr) | 2002-03-15 |
EP1023267A1 (fr) | 2000-08-02 |
JP2001519415A (ja) | 2001-10-23 |
CA2306789A1 (fr) | 1999-04-22 |
WO1999019302A1 (fr) | 1999-04-22 |
DE69818286D1 (de) | 2003-10-23 |
DE69818286T2 (de) | 2004-07-01 |
AU9277198A (en) | 1999-05-03 |
ATE250034T1 (de) | 2003-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH692199A8 (fr) | Composes pyridiques et compositions pharmaceutique | |
MD1233C2 (ro) | Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora | |
NZ236589A (en) | A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions | |
IL100328A0 (en) | Dihydro isoquinoline derivatives,their production and pharmaceutical compositions containing them | |
IL109526A0 (en) | Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
CA2244785A1 (fr) | Pentafluorobenzenesulfonamides et analogues | |
ATE202337T1 (de) | Cyclopropylalkansäurederivate | |
BR9408392A (pt) | Derivados de ácidos arilacéticos e sua utilização como fungicidas | |
RU94038042A (ru) | Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент | |
HUP9601526A2 (hu) | Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
IE792328L (en) | Derivatives of dihydropyrrole and tetrahydropyridine. | |
IT8921513A0 (it) | Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono. | |
GR3034439T3 (en) | 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof | |
IT1276710B1 (it) | Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi | |
SE1214315T5 (fr) | ||
DE69717583D1 (de) | 9-N-Ethenylderivate von 9(S)-Erythromycylamin | |
DE69812059D1 (de) | Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A | |
ES2080445T3 (es) | Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos. | |
SE8505801L (sv) | I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa | |
HUP0002727A2 (hu) | Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával | |
IT1216103B (it) | Peptidi ad attivita' farmaceutica. | |
SE9601483L (sv) | Beredning av komposition | |
MX9803557A (es) | Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producir tales compuestos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PK | Correction |
Free format text: RECTIFICATION DU FASCICULE DU BREVET |
|
PL | Patent ceased |